Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease

NCT05670912 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

105

Enrollment

OTHER

Sponsor class

Stopped Due to the inability to complete subject enrollment and follow-up as originally scheduled, coupled with funding shortages and overall strategic adjustments from the sponsor, the study was terminated on November 12, 2024.

Conditions

Alzheimer Disease

Interventions

DRUG: Wei Li Bai capsules
DRUG: Placebo Comparator of Wei Li Bai capsules

Sponsor

Capital Medical University

Collaborators

[object Object]
[object Object]